Latest Period
Q4 2025
Security Snapshot
Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share (BNGO) Institutional Ownership
CUSIP: 09075F305
13F Institutional Holders and Ownership History from Q1 2022 to Q4 2025
Institutions Reporting
1
Shares (Excl. Options)
1
Price
$2.00
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- BNGO on Nasdaq
- Shares outstanding
- 138,961,039
- Price per share
- $2.00
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 1
- Total reported value
- $2
- Share change
- 0
- Number of holders
- 1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- BNGO - Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 09075F305.
- 1 institution reported positions in Q4 2025.
- 1 significant owner is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 1 to 1 between Q3 2025 and Q4 2025.
- Reported value moved from $2 to $2.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Form 13F
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP 09075F305?
CUSIP 09075F305 identifies BNGO - Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 09075F305:
Significant Owners of Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share (BNGO) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| CVI Investments, Inc. | 7.7% | $1,284,000 | 10,700,000 | CVI Investments, Inc. | 03 Jan 2025 |
As of 31 Dec 2025, 1 institutional investors reported holding 1 shares of Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share (BNGO). This represents 0% of the company’s total 138,961,039 outstanding shares.
Institutional Holders of Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share (BNGO) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 1 | $2 | $2.00 | 1 | |
| 2025 Q3 | 1 | $2 | $2.00 | 1 | |
| 2025 Q2 | 1 | $3 | +$3 | $3.00 | 1 |
| 2025 Q1 | 0 | $0 | -$1,693,509 | $2.00 | 0 |
| 2024 Q4 | 5,875,732 | $1,693,783 | -$84,666 | $0.29 | 41 |
| 2024 Q3 | 5,485,532 | $2,483,366 | -$1,082,119 | $0.45 | 49 |
| 2024 Q2 | 6,607,426 | $4,480,183 | +$918,263 | $0.68 | 52 |
| 2024 Q1 | 4,906,563 | $5,445,185 | -$3,025,598 | $1.11 | 57 |
| 2023 Q4 | 6,172,248 | $11,665,159 | +$790,503 | $1.89 | 67 |
| 2023 Q3 | 5,279,701 | $15,998,487 | +$15,998,486 | $3.03 | 52 |
| 2023 Q2 | 1 | $1 | $1.00 | 1 | |
| 2023 Q1 | 1 | $1 | $1.00 | 1 | |
| 2022 Q4 | 1 | $1 | $1.00 | 1 | |
| 2022 Q3 | 1 | $2 | $2.00 | 1 | |
| 2022 Q2 | 1 | $1 | $1.00 | 1 | |
| 2022 Q1 | 1 | $3 | $3.00 | 1 |